Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 ,inter alia, to consider and approve To Consider and take on Record ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aptus Pharma Ltd has informed BSE that its Board of Directors will meet on Monday, 10th November 2025 to consider and approve the Unaudited Financial Results for the half year ended 30th September 2025, along with the Limited Review Report from auditors. The company has also closed the trading window for insiders, which will remain shut until 48 hours after the results are declared. No specific financial figures have been disclosed in this intimation; the actual numbers will be released post the board meeting on 10th November.
This is a standard pre-results regulatory intimation with no immediate price-moving information. Investors should watch for the actual H1FY26 results on 10th November, as the unaudited numbers and any commentary from management could trigger short-term stock movement.